Cargando…
Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
INTRODUCTION: Although microalbuminuria remains the gold standard for early detection of diabetic nephropathy (DN), it is not a sufficiently accurate predictor of DN risk. Thus, new biomarkers that would help to predict DN risk earlier and possibly prevent the occurrence of end-stage kidney disease...
Autores principales: | Elsheikh, Mohamed, Elhefnawy, Khaled A, Emad, George, Ismail, Mabrouk, Borai, Maher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Nefrologia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979576/ https://www.ncbi.nlm.nih.gov/pubmed/30897192 http://dx.doi.org/10.1590/2175-8239-JBN-2018-0200 |
Ejemplares similares
-
Zinc Alpha 2 Glycoprotein as an Early Biomarker of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients
por: Sonkar, Satyendra K, et al.
Publicado: (2023) -
Erratum: Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
Publicado: (2019) -
Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy
por: Wang, Yuan, et al.
Publicado: (2016) -
MicroRNA-21 as an Early Marker of Nephropathy in Patients with Type 1 Diabetes
por: Fouad, Mohamed, et al.
Publicado: (2020) -
Biomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications
por: Goycheva, Petya, et al.
Publicado: (2023)